Epidemiology of naevi;Epidemiologie des naevus

Annales de Dermatologie et de Venereologie

Volumn 124, Issue 10, 1997, Pages 735-739

  Autier, Ph ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CAUCASIAN; CELL PROLIFERATION; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNE DEFICIENCY; MELANOCYTE; MELANOMA; NEVUS; AGE DISTRIBUTION; FEMALE; GENETICS; MALE; REVIEW; SEX RATIO; SUNBURN; SUNLIGHT;

AGE DISTRIBUTION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; NEVUS; SEX DISTRIBUTION; SUNBURN; SUNLIGHT;

EID: 0030694442     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Bataille V., Newton-Bishop J.A., Sasieni P., Swendlow A.J., Pinney E., Griffiths K., Cuzick J. Risk of cutaneous melanoma in relation to the numbers, types and sites of naevus: a case-control study. Br J Cancer, 1996;73:1605-1611.
2. Carli P., Biggeri A., Giannotti B. Malignant melanoma in Italy: risks associated with common and clinically atypical melanocytic naevus. J Am Acad Dermatol. 1995;32:734-439.
3. Grob J.J, Gouvernet J, Aymar D, Mostaque A., Romano M.H., Collet A.M., Noe M.C., Diconstanzo M.P., Bonerandi J.J. Count of benign melanocytic nevi as a major indicator of risk for nonfamilial nodular and superficial spreading melanoma. Cancer 1990:66:387-395.
4. Ross PM. Apparent absence of a benign precursor lesion: implications for the pathogenesis of malignant melanoma. J Am Acad Dermatol. 1989;21:529-538.
5. Skender-Kalnenas T.M., English D.R., Heenan P.J. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma ? J Am Acad Dermatol, 1995;33:1000-1007.
6. English D.R., MacLennan R., Rivers J., Kelly J. Epidemiological studies of melanocytic naevus: protocol for identifying and recording naevus. IARC Internal Reports No 90/002. International Agency for Research on Cancer, Lyon, 1990.
7. Green A., Siskind V., Green L. The incidence of melanocytic naevus in adolescent children in Queensland, Australia. Mel Res, 1995;5:155-160.
8. Rampen F.H.J., Fleuren B.A.M., de Boo M., Lemmens W.A.J.G. Prevalence of common «acquired » nevocytic nevi and dysplastic nevi is not related to ultraviolet exposure. J Am Acad Dermatol, 1988;18:679-683.
9. Williams M.L., Pennella R. Melanoma, melanocytic nevi, and other melanoma risk factors in children. J Pediatrics 1994;124:833-845.
10. Nichols E.M. Development and elimination of pigmented moles, and the anatomical distribution of primary melanoma. Cancer, 1973;32:191-195.
11. MacKie R., English J., Aitchison T.C., Fitzsimons C.P., Wilson P. The number and distribution of benign pigmented moles (melanocytic naevus) in a healthy British population. Br J Dermatol. 1985;113:167-174.
12. Gallagher R.P., McLean D.I., Yang C.P., Coldman A.J., Silver H.K., Spinelli J.J., Beagrie M.: Anatomic distribution of acquired melanocytic nevi in white children. A comparison with melanoma: the Vancouver Mole Study. Arch Dermatol 1990;126:466-471.
13. Daurès J.P., Sanch-Garnier H., Pourrin-Bourdonneau C., Fisier M., Arnaud C., Grabbar S., Vergnes C., Picot E., Meynadier J. Elude des facteurs démographiques, environnementaux et congénitaux de développement des naevus chez l'enfant entre 3 et 15 ans. Premiers résultats. Rev Epidemiol Santé Publique 1995;43:461-469.
14. Coombs B.D., Sharples K.J., Cooke K.R., Skegg D.C.G., Elwood J.M. Variation and covariates of the number of benign naevus in adolescents. Am J Epid 1992;136:344-355.
15. English D.R., Armstrong B. Melanocytic nevi in children. I. Anatomic sites and demographic and host factors. Am J Epidemiol 1994;139:390 401.
16. Gallagher R.P., McLean D.I., Yang C.P., Coldman A.J., Silver H.K., Spinelli J.J., Beagrie M. Suntan, sunburn, and pigmentation factors and the frequency of acquired melanocytic nevi in children. Similarities to melanoma: the Vancouver Mole Study. Arch Dermatol 1990;126:770-776.
17. Green A. A theory of site distribution of melanomas: Queensland, Australia. Cancer Causes Controls 1992;3:513-526.
18. Abadir M.C., Marghoob A.A., Slade J., Salopek T.G., Yadav S., Kopf A.W. Case-control study of melanocytic nevi on the buttocks in atypical mole syndrome: role of solar radiation in the pathogenesis of atypical moles. J Am Acad Dermatol, 1995;33:31-36.
19. Slade J., Marghoob A.A., Salopek T.G., Rigel D.S., Kopf A.W., Bart R.S. Atypical mole syndrome: risk factor for cutaneous malignant melanoma and implications for clinical management. J Am Acad Dermatol, 1995;32:479-494.
20. Newton J.A., Bataille V., Griffiths K., Squire J.M., Sasieni P., Cuzick J., Bishop D.T. How common is the atypical mole syndrome phenotype in apparently sporadic melanoma ? J Am Acad Dermatol, 1993;29:989-996.
21. Briollais L., Chompret A., Guilloud-Bataille M., Feingold N., Avril M.F., Demenais F. Genetic naevus and epidemiological risk factors for a malignant melanoma-predisposing phenotype: the great number of nevi. Genet Epidemiol, 1996;13:385-402.
22. Armstrong BK, de Klerk NH, Holman CDJ. Etiology of common acquired melanocytic nevi: constitutional variables, sun exposure, and diet. J Nat Cancer Inst 1986;77:329-335.
23. Harrison S.L., MacLennan R., Speare R., Wronski I. Sun exposure and melanocytic naevus in young Australian children. Lancet 1994;344:1529-32.
24. Luther H., Altemeyer P., Garbe C., Ellewanger U, Jahn S, Hoffmann K, Segerling M. Increase of melanocytic nevus counts in children during 5 years of follow-up and analysis of associated factors. Arch Dermatol, 1996;132:1473-1478.
25. Autier P., Doré J.F., Lejeune F., Koelmel K.F., Cheffeler O., Hille P., Cesarini J.P., et al., for the EORTC Melanoma Cooperative Group. Recreational exposure to sunlight and lack of awareness as risk factors for cutaneous malignant melanoma. Results from an EORTC case-control study in Belgium, France and Germany. Mel Res, 1994;4:79-85.
26. Naldi L., Adamoli L., Fraschini D., Corbetta A., Imberti L., Reseghetti A., Reciputo A., et al. Number and distribution of melanocytic nevi in individuals with a history of childhood leukemia. Cancer, 1996:77:1402-1408.
27. Kripke M.L. Effects of UV radiations on tumor immunity. J Natl Cancer Inst. 1990;82; 1392-1396.
28. Kelly JW, Rivers JK, Maclennan R, Harrison S, Lewis A. Tate BJ. Sunlight: a major factor associated with the development of melanocytic nevi in Australian schoolchildren. J Am Acad Dermatol, 1994;30:40-48.
29. Autier P., Doré J.F., Schifflers E., Cesarini J.P., Bollaerts A., Koelmel K.F., Geffeler O., et al., for the EORTC Melanoma Cooperative Group. Melanoma and use of sunscreens: an EORTC case-control study in Germany, Belgium and France. Int J Cancer. 1995;61:749-755.
30. Stierner U., Augustson A., Rosdahl I., Suurkula M. Regional distribution of common and dysplastic naevus in relation to melanoma site and sun exposure: a case-control study. Mel Res, 1991;1:367-375.
31. Swerdlow J., English J., MacKie R.M., O'Doherty C.J., Hunter J.A.A., Clark J., Hole J. Benign melanocytic naevus as a risk factor for malignant melanoma. Br Med J, 1986;292:1555-1559.
32. Rieger E., Soyer H.P., Garbe C., Buttner P., Kofler R, Weiss J., et al. Overall and site-specific risk of malignant melanoma associated with nevus count at different body sites: a multicenter case-control study of the German Central Malignant Melanoma Register. Int J Cancer, 1995;62:393-397.
33. Giles G., Staples M., McCredie M., Coates M. Multiple primary melanomas: an analysis of cancer registry data from Victoria and New South Wales. Mel Res, 1995;5:433-438.